Anti-abuse formulations
There are formulations created to reduce the possibility of drug abuse and misuse, making it difficult to administer it in conditions other than those approved. [...]
Dr. Roberto Gabach: “If it is difficult you plan, if it is impossible you try”
Dr. Gabach, our director & manager of New Projects, analyzes the present and gives us a preview of the future of Amarin and the transdermal market. [...]
Transdermal Drug Delivery Systems and 505(b)(2) / Hybrid Regulatory Pathways.
Transdermal drug delivery systems, also named as “patches”, are controlled release dosage forms designed to deliver a therapeutically effective amount of drug through the skin during the time of application of the product, which may vary between 9 h (methylphenidate) to 148 h (buprenorphine). [...]